Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Accumulated Depreciation (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Accumulated Depreciation for 2 consecutive years, with $838000.0 as the latest value for Q3 2023.

  • On a quarterly basis, Accumulated Depreciation fell 66.81% to $838000.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $838000.0, a 66.81% decrease, with the full-year FY2022 number at $3.2 million, changed N/A from a year prior.
  • Accumulated Depreciation was $838000.0 for Q3 2023 at LENZ Therapeutics, down from $3.3 million in the prior quarter.
  • In the past five years, Accumulated Depreciation ranged from a high of $3.3 million in Q2 2023 to a low of $838000.0 in Q3 2023.